Beta blocker effects on plasma homocysteine levels in patients with hypertension

Atherosclerosis

Volumn 181, Issue 2, 2005, Pages 399-402

  Atar, Ilyas ^a   Korkmaz, Mehmet Emin ^a   Demircan, Şenol ^a   Atar, Inci Asli ^a   Bozbaş, Hüseyin ^a   Aydinalp, Alp ^a   Özin, Bülent ^a   Yildirir, Aylin ^a   Müderrisoǧlu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Beta blocker; Homocysteine; Hypertension

Indexed keywords

BELOC ZOC; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HOMOCYSTEINE; METOPROLOL SUCCINATE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; COMPARATIVE STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; SEX FACTORS; TREATMENT OUTCOME;

EID: 22544433194     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.01.035     Document Type: Article

References (27)

1. K.S. McCully Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
2. U. Lim, and P.A. Cassano Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey Am J Epidemiol 156 2002 1105 1113
3. C.D. Stehouwer, and C. van Guldener Does homocysteine cause hypertension? Clin Chem Lab Med 41 2003 1408 1411
4. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
5. X. Zhang, H. Li, H. Jin, Z. Ebin, S. Brodsky, and M.S. Goligorsky Effects of homocysteine on endothelial nitric oxide production Am J Physiol Renal Physiol 279 2000 671 678
6. S. Voutilainen, J.D. Morrow, and L.J. Roberts Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels Arterioscler Thromb Vasc Biol 19 1999 1263 1266
7. C. van Guldener, and C.D. Stehouwer Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction Semin Thromb Hemost 26 2000 281 289
8. I.M. Graham, L.E. Daly, and H.M. Refsum Plasma homocysteine as a risk factor for vascular disease, The European Concerted Action Project JAMA 277 1997 1775 1781
9. O. Nygard, S.E. Vollset, and H. Refsum Total plasma homocysteine and cardiovascular risk profile, The Hordaland Homocysteine Study JAMA 274 1995 1526 1533
10. P.F. Jacques, A.G. Bostom, P.W. Wilson, S. Rich, I.H. Rosenberg, and J. Selhub Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort Am J Clin Nutr 73 2001 613 621
11. R. Kahleova, D. Palyzova, and K. Zvara Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins Am J Hypertens 15 2002 857 864
12. K. Sutton-Tyrrell, A. Bostom, J. Selhub, and C. Zeigler-Johnson High homocysteine levels are independently related to isolated systolic hypertension in older adults Circulation 96 1997 1745 1749
13. G.Y. Lip, E. Edmunds, S.C. Martin, A.F. Jones, A.D. Blann, and D.G. Beevers A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage Am J Hypertens 14 2001 627 631
14. W.H. Sheu, W.J. Lee, and Y.T. Chen Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects Am J Hypertens 13 2000 14 20
15. S. Neugebauer, L. Tarnow, and C. Stehouwer Total plasma homocysteine is associated with hypertension in Type I diabetic patients Diabetologia 45 2002 1315 1324
16. C. van Guldener, P.W. Nanayakkara, and C.D. Stehouwer Homocysteine and blood pressure Curr Hypertens Rep 5 2003 26 31
17. J. Sundstrom, L. Sullivan, and R.B. D'Agostino Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study Hypertension 42 2003 1100 1105
18. L.E. Morrow, and E.W. Grimsley Long-term diuretic therapy in hypertensive patients: Effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrations South Med J 92 1999 866 870
19. S. Westphal, A. Rading, C. Luley, and J. Dierkes Antihypertensive treatment and homocysteine concentrations Metabolism 52 2003 261 263
20. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med 157 1997 2413 2446
21. R. Rodrigo, W. Passalacqua, J. Araya, M. Orellana, and G. Rivera Homocysteine and essential hypertension J Clin Pharmacol 43 2003 1299 1306
22. R.A. van Dijk, J.A. Rauwerda, M. Steyn, J.W. Twisk, and C.D. Stehouwer Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial Arterioscler Thromb Vasc Biol 21 2001 2072 2079
23. A.A. Mangoni, R.A. Sherwood, C.G. Swift, and S.H. Jackson Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial J Intern Med 252 2002 497 503
24. Y. Sharabi, R. Doolman, and T. Rosenthal Homocysteine levels in hypertensive patients with a history of cardiac or cerebral atherothrombotic events Am J Hypertens 12 1999 766 771
25. K.Q. Do, B. Benz, O. Sorg, L. Pellerin, and P.J. Magistretti Beta-Adrenergic stimulation promotes homocysteic acid release from astrocyte cultures: evidence for a role of astrocytes in the modulation of synaptic transmission J Neurochem 68 1997 2386 2394
26. M.E. Korkmaz, I. Atar, and E. Tayfun Effects of a beta blocker and spironolactone on plasma homocysteine levels Int J Cardiol 91 2003 259 260
27. I. Atar, Ş. Demircan, and M.E. Korkmaz Bireylerde Beta-Bloker ve Spironolaktonun Serum Homosistein Düzeylerine Etkileri Hipertansif MN Kardiyoloji 9 2002 267 271